Impulsivity prevalence in migraine patients without and with medication overuse

ABSTRACT

Background: Migraine is one of the most common disorders in neurological clinical practice and is part of the group of primary headaches. It often affects individuals in the age group of 25-55 years, when people are at their peak of economic productivity. Many patients ultimately overuse analgesics. Overuse is defined by the use of analgesics for at least 15 times a month - within a minimal three-month period. Impulsivity and migraine cause losses in the lives of individuals suffering from them, as they can compromise these individuals’ social, emotional, and professional spheres. Regarding the professional sphere, it results in economic losses compared with the overall population. Objective: To investigate the presence of impulsive behavior in patients with migraine and with medication-overuse migraine. Methods: Cross-sectional study on 210 female and male patients; 140 were diagnosed with migraine according to criteria of the International Classification of Headache Disorders and were subdivided into two groups (70 patients each). One of these groups was composed of medication-overuse patients; the control group was composed of non-migraine patients (70 patients). All patients were evaluated with the Barratt Impulsivity Scale (BIS-11). Results: The group of migraine patients accounted for the highest impulsivity level, followed by the control group and, finally, by the medication-overuse group. However, these differences did not attain statistical significance. Conclusions: It was not possible to establish a clear connection between migraine and impulsive behavior. Association was higher among migraineurs without medication overuse.

RESUMO

Introdução: A enxaqueca é uma das condições mais comuns na prática clínica neurológica, enquadrando-se no grupo das cefaleias primárias. Sua prevalência é maior na faixa etária de 25 a 55 anos, coincidindo com o pico da produtividade econômica. Muitos pacientes recorrem ao uso abusivo de analgésicos. O uso excessivo desses medicamentos é definido pela sua utilização por pelo menos 15 vezes ao mês, por um período de no mínimo três meses. A impulsividade e a enxaqueca causam prejuízos na vida dos indivíduos afetados, podendo comprometer os âmbitos social, emocional e profissional, resultando em um prejuízo monetário a esse grupo, em relação à população em geral. Objetivo: Investigar a presença de comportamento impulsivo em pacientes com enxaqueca com abuso de analgésico. Métodos: Estudo de corte transversal com 210 pacientes, homens e mulheres, sendo 140 com diagnóstico de enxaqueca segundo os critérios da Classificação Internacional das Cefaleias (IHCD-3), subdivididos em dois grupos de 70 pacientes cada, um composto por pacientes em uso excessivo de medicamentos, e um grupo controle composto por indivíduos sem enxaqueca. Todos os pacientes foram avaliados com a Escala de Impulsividade de Barratt - BIS 11. Resultados: O grupo com enxaqueca apresentou maior impulsividade, seguido do grupo controle e, por fim, o grupo com enxaqueca com abuso de medicamentos. No entanto, essas diferenças não atingiram significância estatística. Conclusão: Não foi possível encontrar relação direta entre a enxaqueca e comportamentos impulsivos. No entanto, esta relação foi maior entre os pacientes com enxaqueca sem abuso de analgésico.

Keywords:

Migraine Disorders - Medication Overuse - Impulsive Behavior - Headache

Palavras-chave:

Transtornos de Enxaqueca - Uso Excessivo de Medicamentos Prescritos - Comportamento Impulsivo - Cefaleia

Publication History

Received: 05 May 2020

Accepted: 17 May 2020

Article published online:
07 June 2023

• References

• 1 Ribeiro FA, Anderle F, Grassi V, Barea LM, Stezler G, Reppold C. Avaliação neuropsicológica em pacientes com exaqueca episódica e enxaqueca crônica/cefaleia associada ao uso excessivo de analgésicos. Rev Neuro Psiq. 2017 Jan/Abr;21(1):17-32.
• 2 Brasil Neto JP, Takayangui OM. Tratado de Neurologia da Academia Brasileira de Neurologia. 1. ed. Rio de Janeiro: Elsevier; 2013.
• 3 Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurol Clin. 2009 May;27(2):321-34. https://doi.org/10.1016/j.ncl.2008.11.011
• 4 Headache Classification Committee of the International HeadacheSociety. The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018;33(9):1-211. https://doi.org/10.1177/0333102413485658
• 5 Muñoz I, Hernández M, Pedraza Hueso M, Domínguez E, Ruiz M, Isidro G, et al. Impulsividad en pacientes migrañosos: estudio en una serie de 155 casos. Neurologia. 2016;31(9):599-605. https://doi.org/10.1016/j.nrl.2014.10.006
• 6 Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001 Nov;158(11):1783-93. https://doi.org/10.1176/appi.ajp.158.11.1783
• 7 Tanik N, Akturk T, Saçmaci H, Inan LE. Anger and impulsiveness in migraine patients with and without aura. Neurol Res. 2020 Mar;42(3):253-9. https://doi.org/10.1080/01616412.2020.1723974
• 8 Fortes RC, Vicente JS, Lanzetta BP. O impacto da tontura na qualidade de vida de indivíduos com migrânea. Rev Soc Bras Fonoaudiol. 2010;15(4):520-5. https://doi.org/10.1590/S1516-80342010000400008
• 9 Bigal ME, Fernandes LC, Moraes FA, Bordini CA, Speciali JG. Prevalência e impacto da migrânea em funcionários do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP. Arq Neuro-Psiqiatr. 2000;58(2B):431-6. https://doi.org/10.1590/S0004-282X220200071300007
• 10 Malloy-Diniz LF, Mattos P, Leite WB, Abreu N, Coutinho G, Paula JJ, et al. Tradução e adaptação cultural da Barratt Impulsiveness Scale (BIS-11) para aplicação em adultos brasileiros. J Bras Psiquiatr. 2010;59(2):99-105. https://doi.org/10.1590/S0047-20852010000200004
• 11 Stanford MS, Mathias CW, Dougherty DM, Lake SL, Anderson NE, Patton JH. Fifty years of the Barratt Impulsiveness Scale: an update and review. Pers Individ Dif. 2009;47(5);385-95. https://doi.org/10.1016/j.paid.2009.04.008
• 12 Queiroz LP, Peres MF, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, Zukerman E. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009 Jun;29(6):642-9. https://doi.org/10.1111/j.1468-2982.2008.01782.x
• 13 Chales A. Migraine. N Engl J Med. 2017 Aug;377(6):553-61. https://doi.org/10.1056/NEJMcp1605502
• 14 Evans RW, Matthew NT. Handbook of Headache. Philadelphia: Lippincott Williams & Williams; 2000.
• 15 Goadsby PJ, Lipton RB, Ferrari MD. Drug therapy: migraine current understanding and treatment. N Engl J Med. 2002 Jan;346(4):257-70. https://doi.org/10.1056/NEJMra010917
• 16 Olesen J, Tfelt-Hansen P, Welch KMA. The headaches. 2. ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
• 17 Silberstein SD, Lipton RB, Dalessio Dj. Woff’s headache and other head pain. 7. ed. New York: Oxford University Press; 2001.
• 18 Gentili C, Panicucci P, Guazzelli M. Psychiatric comorbidity and chronicisation in primary headache. J Headache Pain. 2005 Sep;6(4):338-40. https://doi.org/10.1007/s10194-005-0226-6
• 19 Migliorati M, Ricci F, Erbuto D, Bellini S, Pompili M. O070. The association between temperament, depression, hopelessness and quality of life in medication overuse headache patients J Headache Pain. 2015 Sep;16(Suppl 1):A51. https://doi.org/10.1186/1129-2377-16-S1-A51
• 20 Bottiroli S, Allena M, Sances G, De Icco R, Avenali M, Fadic R, et al. Changes in anxiety and depression symptoms associated to the outcome of MOH: a post-hoc analysis of the Comoestas Project. Cephalalgia. 2018 Apr;38(4):646-54. https://doi.org/10.1177/0333102417704415
• 21 Keele NB. The role of serotonin in impulsive and aggresive behaviors associated with epilepsy-like neuronal hyperexcitability in the amygdala. Epilepsy Behav. 2005 Nov;7(3):325-35. https://doi.org/10.1016/j.yebeh.2005.06.014
• 22 Arruda MA, Arruda R, Guidetti V, Bigal ME. ADHD is comorbid to migraine in childhood: a population-based study. J Atten Disord. 2017 Jun;24(7):108705471771076. https://doi.org/10.1177/1087054717710767
• 23 Arruda MA, Guidetti V, Galli F, Albuquerque RC, Bigal ME. Migraine, tension-type headache, and attention-deficit/hyperactivity disorder in childhood: a population-based study. J Postgrad Med. 2010 Sep;122(5):18-26. https://doi.org/10.3810/pgm.2010.09.2197
• 24 Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Pract. 2015 Jan;15(1):4-11. https://doi.org/10.1111/papr.12129
• 25 Scherder EJ, Rommelse NN, Broring T, Faraone SV, Sergeant JA. Somatosensory functioning and experienced pain in ADHD-families: A pilot study. Eur J Paediatr Neurol. 2008 Nov;12(6):461-9. https://doi.org/10.1016/j.ejpn.2007.11.004
• 26 Haveman-Nies A, Jansen SC, Oers JAM, Veer P. Epidemiology in public health practice. Am J Epidemiol. 2011 Sep;174(7):871-2. https://doi.org/10.1093/aje/kwr255